Canada markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.43-1.97 (-6.48%)
At close: 04:00PM EDT
28.85 +0.42 (+1.48%)
After hours: 06:34PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-03-31
2022-03-31
2021-03-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
376,532
493,817
400,146
Total Cash
376,532
493,817
400,146
Net Receivables
700
12,229
596
Other Current Assets
26,916
6,253
7,716
Total Current Assets
404,333
512,931
409,006
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,505
2,633
3,483
Net property, plant and equipment
1,505
2,633
3,483
Total non-current assets
1,505
2,633
3,483
Total Assets
405,838
515,564
412,489
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
1,353
18,629
2,432
Accrued liabilities
32,891
20,119
12,022
Total Current Liabilities
43,297
44,520
18,771
Non-current liabilities
Total non-current liabilities
47
1,219
2,238
Total Liabilities
43,344
45,739
21,009
Stockholders' Equity
Common Stock
13
12
10
Retained Earnings
-566,347
-355,387
-198,657
Accumulated other comprehensive income
852
404
-298
Total stockholders' equity
362,494
469,825
391,480
Total liabilities and stockholders' equity
405,838
515,564
412,489